新型癌症相关疼痛治疗药物 - Suppr

Suppr

超能文献

Emerging drugs for cancer-related pain.

作者信息

Mercadante Sebastiano

出版信息

Support Care Cancer. 2011 Dec;19(12):1887-93. doi: 10.1007/s00520-011-1281-y. Epub 2011 Sep 23.

DOI:10.1007/s00520-011-1281-y

PMID:21938596

Abstract

摘要

相似文献

Emerging drugs for cancer-related pain.

Support Care Cancer. 2011 Dec;19(12):1887-93. doi: 10.1007/s00520-011-1281-y. Epub 2011 Sep 23.

Pain relief in terminally ill patients.

Am Fam Physician. 1989 Dec;40(6):133-40.

Drug therapy in cancer pain.

J Med Assoc Ga. 1991 May;80(5):295-300.

Is the WHO analgesic ladder still valid? Twenty-four years of experience.

Can Fam Physician. 2010 Jun;56(6):514-7, e202-5.

[Cancer pain: therapy according to the pain relief ladder].

MMW Fortschr Med. 2010 May 27;152(21):91-3, 95; quiz 96. doi: 10.1007/BF03366650.

Cancer pain: pharmacological management (Part Two).

J Med Liban. 1993;41(4):244-8.

The scientific basis for analgesic use in dentistry.

Anesth Prog. 1986 May-Jun;33(3):123-38.

The importance of non-opioid analgesics for cancer pain relief according to the guidelines of the World Health Organization.

Int J Clin Pharmacol Res. 1991;11(6):253-60.

Opioid and adjuvant analgesics: compared and contrasted.

Am J Hosp Palliat Care. 2011 Aug;28(5):378-83. doi: 10.1177/1049909111410298. Epub 2011 May 26.

[Controlling pain effectively in the elderly. Age is not an analgesic].

MMW Fortschr Med. 2006 May 11;148(19):12-3.

引用本文的文献

Factors associated with non-response to naldemedine for opioid-induced constipation in cancer patients: A subgroup analysis.

PLoS One. 2022 Dec 9;17(12):e0278823. doi: 10.1371/journal.pone.0278823. eCollection 2022.

Incidence of opioid-induced constipation in Japanese patients with cancer pain: A prospective observational cohort study.

Cancer Med. 2019 Aug;8(10):4883-4891. doi: 10.1002/cam4.2341. Epub 2019 Jun 24.

Cancer pain therapy with a fixed combination of prolonged-release oxycodone/naloxone: results from a non-interventional study.

Pragmat Obs Res. 2013 Dec 19;5:1-13. doi: 10.2147/POR.S49793. eCollection 2014.

Ready conversion of patients with well-controlled, moderate to severe, chronic malignant tumor-related pain on other opioids to tapentadol extended release.

Clin Drug Investig. 2014 Jul;34(7):501-11. doi: 10.1007/s40261-014-0204-3.

Spider peptide Phα1β induces analgesic effect in a model of cancer pain.

Cancer Sci. 2013 Sep;104(9):1226-30. doi: 10.1111/cas.12209. Epub 2013 Jun 25.

本文引用的文献

Effectiveness of antiepileptic or antidepressant drugs when added to opioids for cancer pain: systematic review.

Palliat Med. 2011 Jul;25(5):553-9. doi: 10.1177/0269216310378546. Epub 2010 Jul 29.

Pharmacokinetics of intranasal fentanyl spray in patients with cancer and breakthrough pain.

J Opioid Manag. 2010 Jan-Feb;6(1):17-26. doi: 10.5055/jom.2010.0001.

Efficacy of intranasal fentanyl spray versus other opioids for breakthrough pain in cancer.

Curr Med Res Opin. 2010 May;26(5):1037-45. doi: 10.1185/03007991003694340.

Tapentadol hydrochloride: a centrally acting oral analgesic.

Clin Ther. 2009 Dec;31(12):2804-18. doi: 10.1016/j.clinthera.2009.12.003.

Combined oral prolonged-release oxycodone and naloxone in opioid-induced bowel dysfunction: review of efficacy and safety data in the treatment of patients experiencing chronic pain.

Expert Opin Pharmacother. 2010 Feb;11(2):297-310. doi: 10.1517/14656560903483222.

Clinical implications of opioid pharmacogenetics.

Clin J Pain. 2010 Jan;26 Suppl 10:S16-20. doi: 10.1097/AJP.0b013e3181c49e11.

Sublingual administration of fentanyl to cancer patients is an effective treatment for breakthrough pain: results from a randomized phase II study.

Palliat Med. 2010 Apr;24(3):286-93. doi: 10.1177/0269216309356138. Epub 2009 Dec 16.

Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain.

J Pain Symptom Manage. 2010 Feb;39(2):167-79. doi: 10.1016/j.jpainsymman.2009.06.008. Epub 2009 Nov 5.

Efficacy and long-term tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain.

Curr Med Res Opin. 2009 Dec;25(12):2877-85. doi: 10.1185/03007990903368310.

A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomised, crossover trial.

Curr Med Res Opin. 2009 Nov;25(11):2805-15. doi: 10.1185/03007990903336135.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验